[HTML][HTML] Oxidative stress in cardiovascular diseases: still a therapeutic target?

T Senoner, W Dichtl - Nutrients, 2019 - mdpi.com
Cardiovascular diseases (CVD) are complex entities with heterogenous pathophysiologic
mechanisms and increased oxidative stress has been viewed as one of the potential …

[HTML][HTML] Vitamin D and endothelial function

DH Kim, CA Meza, H Clarke, JS Kim, RC Hickner - Nutrients, 2020 - mdpi.com
Vitamin D is known to elicit a vasoprotective effect, while vitamin D deficiency is a risk factor
for endothelial dysfunction (ED). ED is characterized by reduced bioavailability of a potent …

RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and …

D Karunakaran, MA Nguyen, M Geoffrion, D Vreeken… - Circulation, 2021 - Am Heart Assoc
Background: Chronic activation of the innate immune system drives inflammation and
contributes directly to atherosclerosis. We previously showed that macrophages in the …

Polymeric nanostructures for imaging and therapy

M Elsabahy, GS Heo, SM Lim, G Sun… - Chemical …, 2015 - ACS Publications
Medical diagnosis and therapy are essential for providing patients with proper care,
although inefficient diagnosis and therapy are usually associated with either improper …

The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation

GJ Martinez, DS Celermajer, S Patel - Atherosclerosis, 2018 - Elsevier
Atherosclerosis is considered a chronic inflammatory disease of the arterial wall. Recently,
compelling evidence has arisen for the role of monocytes and neutrophils and a particular …

Phospholipase A2 Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention

EA Dennis, J Cao, YH Hsu, V Magrioti… - Chemical …, 2011 - ACS Publications
1.1. Discovery of the Phospholipase A2 Superfamily Phospholipases represent one of the
earliest enzyme activities to be identified and studied, and the phospholipase A2 (PLA2) …

[HTML][HTML] Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009

RA DeFronzo - Diabetologia, 2010 - Springer
Insulin resistance is a hallmark of type 2 diabetes mellitus and is associated with a metabolic
and cardiovascular cluster of disorders (dyslipidaemia, hypertension, obesity [especially …

Dapagliflozin exerts anti-inflammatory effects via inhibition of LPS-induced TLR-4 overexpression and NF-κB activation in human endothelial cells and differentiated …

E Abdollahi, F Keyhanfar, AA Delbandi, R Falak… - European Journal of …, 2022 - Elsevier
Evidence has demonstrated that a new class of anti-diabetic drugs, sodium-glucose co-
transporter 2 (SGLT2) inhibitors, could exert beneficial effects on atherosclerotic …

Monocytes in coronary artery disease and atherosclerosis: where are we now?

A Ghattas, HR Griffiths, A Devitt, GYH Lip… - Journal of the American …, 2013 - jacc.org
Despite improvements in interventional and pharmacological therapy of atherosclerotic
disease, it is still the leading cause of death in the developed world. Hence, there is a need …

New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway

ZH Tang, J Peng, Z Ren, J Yang, TT Li, TH Li, Z Wang… - Atherosclerosis, 2017 - Elsevier
Background and aims Proprotein convertase subtilisin/kexin 9 (PCSK9) has emerged as a
popular target in the development of new cholesterol-lowering drugs and therapeutic …